Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | bafilomycin A1 | CTRPv2 | pan-cancer | AAC | 0.047 | 0.7 |
mRNA | KIN001-270 | GDSC1000 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | BRD-K16147474 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | L-685458 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | BRD-A05715709 | CTRPv2 | pan-cancer | AAC | 0.021 | 0.7 |
mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | SN-38 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.018 | 0.7 |
mRNA | Vinblastine | GDSC1000 | pan-cancer | AAC | 0.013 | 0.7 |